Clinical Trial: A Trial to Learn if Odronextamab is Safe and Well-tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Follicular Lymphoma (FL)
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 X Anti-CD3 Bispecific Antibody Versus Investigator's Choice in Previously Untre
Brief Summary:
This study is researching an experimental drug called odronextamab, referred to as study drug.The study is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL).This study will be made up of two parts: Part 1 (non-randomized) and Part 2 (randomized - controlled).The aim of Part 1 of the study is to see how safe and tolerable the study drug is.The aim of Part 2 of the study is to see how the study drug works compared to rituximab and chemotherapy (the current…
Read more